These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 6514071)

  • 1. The effect of converting enzyme inhibition on the enhanced proximal sodium reabsorption induced by chronic diuretic treatment in patients with essential hypertension.
    van Schaik BA; Geyskes GG; Dorhout Mees EJ
    Nephron; 1987; 47(3):167-72. PubMed ID: 2825050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in intrarenal uric acid handling during chronic spironolactone treatment in patients with essential hypertension.
    Roos JC; Boer P; Peuker KH; Dorhout Mees EJ
    Nephron; 1982; 32(3):209-13. PubMed ID: 7155242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in intrarenal sodium handling during saluretic treatment in patients with essential hypertension.
    Roos JC; Dorhout Mees EJ; Koomans HA; Geyskes GG; Boer P
    Acta Med Scand; 1981; 210(1-2):79-84. PubMed ID: 7027748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of volume expansion on NaC1 reabsorption in the diluting segments of the nephron: a study using clearance methods.
    Danovitch GM; Bricker NS
    Kidney Int; 1976 Sep; 10(3):229-38. PubMed ID: 972443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in response to drugs.
    Rawlins MD
    Br Med J; 1974 Oct; 4(5936):91-4. PubMed ID: 4607336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrarenal sodium handling during chronic spironolactone treatment.
    Roos JC; Dorhout Mees EJ; Koomans HA; Boer P
    Nephron; 1984; 38(4):226-32. PubMed ID: 6514071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative effects of chlorthalidone on sympathetic nervous system and insulin resistance in hypertensive patients may be avoided with spironolactone: further studies are still needed.
    Castro-Torres Y; Fleites-Pérez A; Carmona-Puerta R; Jiménez-Garrido RG
    Ir J Med Sci; 2015 Dec; 184(4):727-9. PubMed ID: 26341505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of insulin on renal sodium metabolism. A review with clinical implications.
    DeFronzo RA
    Diabetologia; 1981 Sep; 21(3):165-71. PubMed ID: 7028550
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.